Anti-Glaucoma Eye Drops Franchise in Ahmedabad

Timolol + Brimonidine Eye Drops Supplier in Mumbai

Ophthalmic Glaucoma Care Distributor in Delhi

Eye Pressure Control Pharma Franchise in Bangalore

Timolol Brimonidine Eye Drops Stockist in Hyderabad
Anti-Glaucoma Combination Ophthalmic Drop Manufacturer & Exporter in Chandigarh

Home/Products /timolol-5mg-ml-brimonidine-1-5mg-ml-eye-drop

Timshell B 1.5 Eye Drop

Composition : Timolol (5mg/ml) + Brimonidine (1.5mg/ml) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹1/-

Travopine B 1.5 Eye Drop contains Timolol 5mg/ml + Brimonidine 1.5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its well-balanced combination ensures reliable and sustained pressure control.

The eye drop works by reducing aqueous humor production through Timolol and decreasing aqueous formation while enhancing outflow via Brimonidine, providing comprehensive intraocular pressure management and optic nerve protection.

From a franchise perspective, Travopine B 1.5 Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, ophthalmology clinics, and glaucoma care centers, ensuring steady prescriptions and repeat business.

Adding Travopine B 1.5 Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Read More

About the Product

Travopine B 1.5 Eye Drop contains Timolol 5mg/ml + Brimonidine 1.5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its well-balanced combination ensures reliable and sustained pressure control.

The eye drop works by reducing aqueous humor production through Timolol and decreasing aqueous formation while enhancing outflow via Brimonidine, providing comprehensive intraocular pressure management and optic nerve protection.

From a franchise perspective, Travopine B 1.5 Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, ophthalmology clinics, and glaucoma care centers, ensuring steady prescriptions and repeat business.

Adding Travopine B 1.5 Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Common side effects may include burning or stinging sensation, eye redness, dryness, itching, or blurred vision. Systemic effects such as fatigue, dizziness, dry mouth, slow heart rate, or drowsiness may occur rarely, especially in susceptible individuals.

Travopine B 1.5 Eye Drop is indicated for the management of open-angle glaucoma and ocular hypertension in patients who require combination therapy for adequate intraocular pressure reduction. It is used under the supervision of an ophthalmologist.

Use Travopine B 1.5 Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with asthma, COPD, cardiovascular disease, or those taking antihypertensive medications. Seek medical advice immediately if breathing difficulty, severe eye irritation, or vision changes occur.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation